These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20653825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SOX-10 staining in dermal scars.
    Behrens EL, Boothe W, D'Silva N, Walterscheid B, Watkins P, Tarbox M.
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [Abstract] [Full Text] [Related]

  • 5. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D, Qi W, Ra S, Bremer R, Yu C, Chu J, Hoang L, Robbins B.
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C.
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [Abstract] [Full Text] [Related]

  • 10. Identification of nodal metastases in melanoma using sox-10.
    Jennings C, Kim J.
    Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SOX10 commonly stains scar in Mohs sections.
    Donaldson MR, Weber LA.
    Dermatol Online J; 2020 Jan 15; 26(1):. PubMed ID: 32155034
    [Abstract] [Full Text] [Related]

  • 13. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B, Su A, Binder S, Dry S.
    Am J Dermatopathol; 2013 Jul 15; 35(5):576-81. PubMed ID: 23291581
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN, Prieto VG, Torres-Cabala C, Suster S, Plaza JA.
    Am J Dermatopathol; 2014 Feb 15; 36(2):124-30. PubMed ID: 23782678
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG, Burchette JL, Selim MA, Pham T, Soler AP.
    Hum Pathol; 2006 Jul 15; 37(7):899-905. PubMed ID: 16784991
    [Abstract] [Full Text] [Related]

  • 16. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S, Jukic DM, Drogowski L, Bhawan J, Radfar A.
    Am J Dermatopathol; 2011 Feb 15; 33(1):65-71. PubMed ID: 21178583
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical characteristics of melanoma.
    Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.
    J Cutan Pathol; 2008 May 15; 35(5):433-44. PubMed ID: 18399807
    [Abstract] [Full Text] [Related]

  • 18. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C.
    Appl Immunohistochem Mol Morphol; 2013 Dec 15; 21(6):506-10. PubMed ID: 23197006
    [Abstract] [Full Text] [Related]

  • 19. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M, Sooman L, Bolander A, Strömberg S, Rexhepaj E, Bergqvist M, Ponten F, Gallagher W, Lennartsson J, Ekman S, Uhlen M, Hedstrand H.
    Melanoma Res; 2010 Dec 15; 20(6):468-78. PubMed ID: 20890226
    [Abstract] [Full Text] [Related]

  • 20. Potentially useful markers for desmoplastic melanoma: an analysis of KBA.62, p-AKT, and ezrin.
    Bernaba BN, Vogiatzis PI, Binder SW, Cassarino DS.
    Am J Dermatopathol; 2011 Jun 15; 33(4):333-7; quiz 338-40. PubMed ID: 21610456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.